Morteza Khademalhosseini Selected Research

Morteza Khademalhosseini Research Topics

4	Neoplasms (Cancer) 05/2023 - 05/2019
2	Breast Neoplasms (Breast Cancer) 05/2023 - 05/2019
1	Cognitive Dysfunction 09/2023
1	Neoplasm Metastasis (Metastasis) 05/2023
1	Substance-Related Disorders (Drug Abuse) 02/2021
1	Overweight 01/2021
1	Alcoholic Cardiomyopathy 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Obesity 01/2021
1	Migraine Disorders (Migraine) 05/2019

2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2019
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2021
1	Vitamin D FDA LinkGeneric 09/2023
1	Sirtuin 1IBA 09/2023
1	DAPIIBA 05/2023
1	4- oxo- 6- ((pyrimidin- 2- ylthio)methyl)- 4H- pyran- 3- yl 4-nitrobenzoateIBA 05/2023
1	ApelinIBA 05/2023
1	Apelin ReceptorsIBA 05/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2023
1	Hematoxylin (Haematoxylon)IBA 05/2023
1	Messenger RNA (mRNA)IBA 05/2023
1	VaccinesIBA 05/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2023
1	Interleukin-9 (Interleukin 9)IBA 05/2023
1	Matrix Metalloproteinases (MMPs)IBA 05/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2021
1	Protective AgentsIBA 01/2021
1	Calcium DobesilateIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Toll-Like Receptor 4IBA 05/2019
1	Sumatriptan (Imigran)FDA LinkGeneric 05/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2019
1	Serotonin (5 Hydroxytryptamine)IBA 05/2019

1	Therapeutics 05/2023